SCHEMBL6322990

SCHEMBL6322990

CC(C)(C)OC(=O)CCC(=O)c1ccc(OCc2c(F)cccc2F)cc1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAOB P27338 4/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
GAA P10253 1/20 0.43
EGFR P00533 2/20 0.41
PARP15 Q460N3 1/20 0.40
PARP14 Q460N5 1/20 0.40
PARP10 Q53GL7 1/20 0.40
MMP1 P03956 1/20 0.40
NPC1 O15118 1/20 0.40
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
ALKBH1 Q13686 1/20 0.38
RAB9A P51151 1/20 0.38
GRM5 P41594 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2087543 0.84 NPC1 (0.47) MAOBL3MBTL1EGFRPARP15PARP14
SCHEMBL958298 0.82 NR4A2 (0.49) MAOBKMT2AGAAEGFRPARP15
SCHEMBL4096578 0.77 LMNA (0.59) MEN1KMT2AL3MBTL1GAANPC1
SCHEMBL2090015 0.76 GSK3B (0.50) MAOBPARP15PARP14PARP10NPC1
SCHEMBL2641408 0.76 MEN1 (0.38) MAOBMEN1KMT2AL3MBTL1GAA
SCHEMBL2086618 0.76 ALDH1A1 (0.40) MAOBMEN1KMT2AL3MBTL1GAA
SCHEMBL6763543 0.76 ALDH1A1 (0.40) MAOBMEN1KMT2AL3MBTL1GAA
SCHEMBL2087289 0.76 MAOB (0.70) MAOBL3MBTL1GAA
SCHEMBL13304061 0.76 MMP1 (0.58) MEN1KMT2AL3MBTL1MMP1NPC1
SCHEMBL6322991 0.75 MAOB (0.42) MAOBMEN1KMT2AGAAEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102151262-A Compounds for the treatment of metabolic disorders WELLSTAT THERAPEUTICS CORP 2011-08-17 CN disclosed
CN-102140064-A Compounds for the treatment of metabolic disorders WELLSTAT THERAPEUTICS CORP 2011-08-03 CN disclosed
CN-101444496-B Compounds for the treatment of metabolic disorders WELLSTAT THERAPEUTICS CORP 2011-04-13 CN disclosed
CN-101444496-A Compounds for the treatment of metabolic disorders WELLSTAT THERAPEUTICS CORP (US) 2009-06-03 CN disclosed
CN-1608055-A Compounds for the treatment of metabolic disorders WELLSTAT THERAPEUTICS CORP (US) 2005-04-20 CN disclosed
US-6858602-B2 Compounds for the treatment of metabolic disorders WELLSTAT THERAPEUTICS CORPORATION (US) 2005-02-22 US disclosed